PSMD1 and sclerosing cholangitis: The unexpected finding was the average anti-S1 Ab titer >40.000 AU/mL after the second dose in the LTR group with autoimmune primary liver diseases (primary sclerosing cholangitis or autoimmune hepatitis), which confirmed previous observations that autoimmunity itself does not hamper vaccination responses [28].